Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Pro
Lung cancer continues to be the leading cause of cancer death in the United States. There are several important disparities in lung cancer mortality: racial and ethnic minorities, those with serious mental illness and those with lower socioeconomic status experience higher lung cancer mortality compared to the general
| Condition(s) | Lung Cancer Screening Program |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Lung cancer continues to be the leading cause of cancer death in the United States. There are several important disparities in lung cancer mortality: racial and ethnic minorities, those with serious mental illness and those with lower socioeconomic status experience higher lung cancer mortality compared to the general population. Lung cancer screening (LCS) with annual low dose chest CT can reduce lung cancer mortality by 20% for high-risk patients, but has been generally underutilized with uptake of 5-15% by eligible patients across the United States. Half of all patients eligible for LCS remain current smokers, and the additional benefits of tobacco cessation services can increase the benefits of LCS clinical encounters in these patients. Despite the proven benefit of LCS and tobacco ces |
| Who can participate | Inclusion Criteria: * 50-80 years of age * greater than or equal to 20 pack year history * currently smoking or have quit within the last 15 years Exclusion Criteria: * \< 50 years of age, \> 80 years of age * \< 20 pack year history * quit smoking greater than 15 years |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Physician Affiliate Group of New York |
| Locations | New York, New York, United States |
| Start date | 2025-03-10 |
| NCT ID | NCT06876831 |
| Official listing | https://clinicaltrials.gov/study/NCT06876831 |